My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 304

    1.

    EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer.

    Pietersen AM, Horlings HM, Hauptmann M, Langerød A, Ajouaou A, Cornelissen-Steijger P, Wessels LF, Jonkers J, van de Vijver MJ, van Lohuizen M.

    Breast Cancer Res. 2008;10(6):R109. Epub 2008 Dec 19.PMID: 19099573 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.

    Berezovska OP, Glinskii AB, Yang Z, Li XM, Hoffman RM, Glinsky GV.

    Cell Cycle. 2006 Aug;5(16):1886-901. Epub 2006 Aug 15.PMID: 16963837 [PubMed - indexed for MEDLINE]Related articles

    3.

    Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.

    van Leenders GJ, Dukers D, Hessels D, van den Kieboom SW, Hulsbergen CA, Witjes JA, Otte AP, Meijer CJ, Raaphorst FM.

    Eur Urol. 2007 Aug;52(2):455-63. Epub 2006 Nov 17.PMID: 17134822 [PubMed - indexed for MEDLINE]Related articles

    4.

    Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1.

    Hernández-Muñoz I, Taghavi P, Kuijl C, Neefjes J, van Lohuizen M.

    Mol Cell Biol. 2005 Dec;25(24):11047-58.PMID: 16314526 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence.

    Agherbi H, Gaussmann-Wenger A, Verthuy C, Chasson L, Serrano M, Djabali M.

    PLoS One. 2009 May 20;4(5):e5622.PMID: 19462008 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    BMI1 sustains human glioblastoma multiforme stem cell renewal.

    Abdouh M, Facchino S, Chatoo W, Balasingam V, Ferreira J, Bernier G.

    J Neurosci. 2009 Jul 15;29(28):8884-96.PMID: 19605626 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma.

    Yonemitsu Y, Imazeki F, Chiba T, Fukai K, Nagai Y, Miyagi S, Arai M, Aoki R, Miyazaki M, Nakatani Y, Iwama A, Yokosuka O.

    Hum Pathol. 2009 Sep;40(9):1304-11. Epub 2009 Apr 22.PMID: 19386347 [PubMed - indexed for MEDLINE]Related articles

    8.

    pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene.

    Kotake Y, Cao R, Viatour P, Sage J, Zhang Y, Xiong Y.

    Genes Dev. 2007 Jan 1;21(1):49-54.PMID: 17210787 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells.

    Bracken AP, Kleine-Kohlbrecher D, Dietrich N, Pasini D, Gargiulo G, Beekman C, Theilgaard-Mönch K, Minucci S, Porse BT, Marine JC, Hansen KH, Helin K.

    Genes Dev. 2007 Mar 1;21(5):525-30.PMID: 17344414 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma.

    Sasaki M, Ikeda H, Itatsu K, Yamaguchi J, Sawada S, Minato H, Ohta T, Nakanuma Y.

    Lab Invest. 2008 Aug;88(8):873-82. Epub 2008 Jun 30.PMID: 18591938 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.

    Silva J, García JM, Peña C, García V, Domínguez G, Suárez D, Camacho FI, Espinosa R, Provencio M, España P, Bonilla F.

    Clin Cancer Res. 2006 Dec 1;12(23):6929-36.PMID: 17145810 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene.

    Raaphorst FM, Meijer CJ, Fieret E, Blokzijl T, Mommers E, Buerger H, Packeisen J, Sewalt RA, Otte AP, van Diest PJ.

    Neoplasia. 2003 Nov-Dec;5(6):481-8.PMID: 14965441 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis.

    Sasaki M, Yamaguchi J, Itatsu K, Ikeda H, Nakanuma Y.

    J Pathol. 2008 Jun;215(2):175-83.PMID: 18393368 [PubMed - indexed for MEDLINE]Related articles

    14.

    Bmi1 functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis.

    Xu CR, Lee S, Ho C, Bommi P, Huang SA, Cheung ST, Dimri GP, Chen X.

    Mol Cancer Res. 2009 Dec;7(12):1937-45. Epub 2009 Nov 24.PMID: 19934271 [PubMed - indexed for MEDLINE]Related articles

    15.

    MAPKAP kinase 3pK phosphorylates and regulates chromatin association of the polycomb group protein Bmi1.

    Voncken JW, Niessen H, Neufeld B, Rennefahrt U, Dahlmans V, Kubben N, Holzer B, Ludwig S, Rapp UR.

    J Biol Chem. 2005 Feb 18;280(7):5178-87. Epub 2004 Nov 24.PMID: 15563468 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    E2f6 and Bmi1 cooperate in axial skeletal development.

    Courel M, Friesenhahn L, Lees JA.

    Dev Dyn. 2008 May;237(5):1232-42.PMID: 18366140 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Bmi1 deficient neural stem cells have increased integrin dependent adhesion to self-secreted matrix.

    Bruggeman SW, Hulsman D, van Lohuizen M.

    Biochim Biophys Acta. 2009 May;1790(5):351-60. Epub 2009 Mar 16.PMID: 19298843 [PubMed - indexed for MEDLINE]Related articles

    18.

    E4F1: a novel candidate factor for mediating BMI1 function in primitive hematopoietic cells.

    Chagraoui J, Niessen SL, Lessard J, Girard S, Coulombe P, Sauvageau M, Meloche S, Sauvageau G.

    Genes Dev. 2006 Aug 1;20(15):2110-20.PMID: 16882984 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma.

    Bruggeman SW, Hulsman D, Tanger E, Buckle T, Blom M, Zevenhoven J, van Tellingen O, van Lohuizen M.

    Cancer Cell. 2007 Oct;12(4):328-41.PMID: 17936558 [PubMed - indexed for MEDLINE]Related articles

    20.

    Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.

    Hoffmann MJ, Engers R, Florl AR, Otte AP, Muller M, Schulz WA.

    Cancer Biol Ther. 2007 Sep;6(9):1403-12.PMID: 18637271 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk